Role of CCR5 in Infection of Primary Macrophages and Lymphocytes by Macrophage-tropic Strains of Human Immunodeficiency Virus: Resistance to Patient-derived and Prototype Isolates Resulting from the Delta Ccr5 Mutation
Overview
Authors
Affiliations
The alpha-chemokine receptor fusin (CXCR-4) and beta-chemokine receptor CCR5 serve as entry cofactors for T-cell (T)-tropic and macrophage (M)-tropic human immunodeficiency virus type 1 (HIV-1) strains, respectively, when expressed with CD4 in otherwise nonpermissive cells. Some M-tropic and dual-tropic strains can also utilize other beta-chemokine receptors, such as CCR2b and CCR3. A mutation of CCR5 (delta ccr5) was recently found to be common in certain populations and appears to confer protection against HIV-1 in vivo. Here, we show that this mutation results in a protein that is expressed intracellularly but not on the cell surface. Primary CD4 T cells from delta ccr5 homozygous individuals were highly resistant to infection with prototype M-tropic HIV-1 strains, including an isolate (YU-2) that uses CCR5 and CCR3, but were permissive for both a T-tropic strain (3B) and a dual-tropic variant (89.6) that uses CXCR-4, CCR5, CCR3, or CCR2b. These cells were also resistant to M-tropic patient isolates but were readily infected by T-tropic patient isolates. Primary macrophages from delta ccr5 homozygous individuals were also resistant to infection with M-tropic strains, including YU-2, but the dual-tropic strain 89.6 was able to replicate in them even though macrophages are highly resistant to CXCR-4-dependent T-tropic isolates. These data show that CCR5 is the essential cofactor for infection of both primary macrophages and T lymphocytes by most M-tropic strains of HIV-1. They also suggest that CCR3 does not function for HIV-1 entry in primary lymphocytes or macrophages, but that a molecule(s) other than CCR5 can support entry into macrophages by certain virus isolates. These studies further define the cellular basis for the resistance to HIV-1 infection of individuals lacking functional CCR5.
Rezaei S, Timani K, Liu Y, He J Front Cell Infect Microbiol. 2024; 14():1371655.
PMID: 39624264 PMC: 11609158. DOI: 10.3389/fcimb.2024.1371655.
Dong S, Vizeacoumar F, Bhanumathy K, Alli N, Gonzalez-Lopez C, Gajanayaka N BMC Infect Dis. 2021; 21(1):655.
PMID: 34233649 PMC: 8261936. DOI: 10.1186/s12879-021-06346-7.
Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120.
Rios S, Colon Saez J, Quesada O, Figueroa K, Lasalde Dominicci J J Biol Chem. 2021; 296:100618.
PMID: 33811859 PMC: 8102909. DOI: 10.1016/j.jbc.2021.100618.
Rautenbach A, Williams A Int J Mol Sci. 2020; 21(4).
PMID: 32098198 PMC: 7073144. DOI: 10.3390/ijms21041472.
Arendt V, Amand M, Iserentant G, Lemaire M, Masquelier C, Ndayisaba G J Int AIDS Soc. 2019; 22(9):e25384.
PMID: 31486251 PMC: 6727025. DOI: 10.1002/jia2.25384.